It is unclear whether they derive from MDSCs recruited into tumours and subsequently transformed, or from circulating neutrophils that acquire the N2 phenotype under the influence of tumour-derived TGF-β (40, 43). The gene discussed is TGFB1; the disease is neoplasm.